Literature DB >> 9157133

Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis.

E Mahenthiralingam1, D A Simpson, D P Speert.   

Abstract

Burkholderia cepacia is a problematic pathogen that may spread among patients with cystic fibrosis (CF). One highly infectious CF strain that causes epidemics in both the United Kingdom and eastern Canada has been shown to possess both the cable pilin subunit gene (cblA) and a unique combination of insertion sequences. However, no genetic markers linking this strain type with other types epidemic at various centers have been identified. Using a randomly amplified polymorphic DNA (RAPD) typing scheme, we identified an apparently conserved 1.4-kb fragment in the DNA fingerprint of epidemic B. cepacia strains. Conservation of the DNA marker among epidemic strains was demonstrated by Southern hybridization, and its prevalence was assessed in a collection of chromosomal DNAs extracted from 627 isolates representative of 132 RAPD-defined B. cepacia strain types. The marker was specifically associated with seven epidemic CF strains, was absent among nonepidemic strains infecting individual patients with CF, and rare among strains recovered from the natural environment. Only one of the seven epidemic CF strain types possessed DNA homologous to cblA. The RAPD marker was designated the "B. cepacia epidemic strain marker" (BCESM). Sequence analysis of chromosomal DNA corresponding to the 1.4-kb RAPD marker revealed the presence of a putative open reading frame (ORF) with significant homology to several negative transcriptional regulators; the ORF was designated the "epidemic strain marker regulator," or esmR. The BCESM DNA is the first genetic marker that has been identified to be specifically associated with and conserved among several epidemic B. cepacia strains which infect multiple patients with CF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9157133      PMCID: PMC229681          DOI: 10.1128/jcm.35.4.808-816.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

Review 1.  Virulence factors of Burkholderia cepacia.

Authors:  J W Nelson; S L Butler; D Krieg; J R Govan
Journal:  FEMS Immunol Med Microbiol       Date:  1994-02

2.  Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

Authors:  S L Butler; C J Doherty; J E Hughes; J W Nelson; J R Govan
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

3.  Protein family classification based on searching a database of blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Genomics       Date:  1994-01-01       Impact factor: 5.736

4.  Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa.

Authors:  N Høiby
Journal:  Neth J Med       Date:  1995-06       Impact factor: 1.422

5.  Analysis of the Escherichia coli genome VI: DNA sequence of the region from 92.8 through 100 minutes.

Authors:  V Burland; G Plunkett; H J Sofia; D L Daniels; F R Blattner
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

6.  Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Differences in eucaryotic cell binding of Pseudomonas.

Authors:  M A Cervin; D A Simpson; A L Smith; S Lory
Journal:  Microb Pathog       Date:  1994-11       Impact factor: 3.738

8.  Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia.

Authors:  R Goldstein; L Sun; R Z Jiang; U Sajjan; J F Forstner; C Campanelli
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

9.  Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers.

Authors:  U S Sajjan; L Sun; R Goldstein; J F Forstner
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

10.  Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense.

Authors:  D P Speert; M Bond; R C Woodman; J T Curnutte
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

View more
  61 in total

1.  Pseudomonas and all that.

Authors:  C A Hart; C Winstanley
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

2.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 4.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

5.  Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.

Authors:  Sylvain Brisse; Stefania Stefani; Jan Verhoef; Alex Van Belkum; Peter Vandamme; Wil Goessens
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

6.  Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil.

Authors:  Maria G Detsika; John E Corkill; Marcelo Magalhães; Kerry J Glendinning; C Anthony Hart; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

Review 7.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

8.  Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

Authors:  J E Hughes; J Stewart; G R Barclay; J R Govan
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

9.  Detection of heme-binding proteins in epidemic strains of Burkholderia cepacia.

Authors:  J W Smalley; P Charalabous; A J Birss; C A Hart
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

10.  Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence.

Authors:  C Kooi; B Subsin; R Chen; B Pohorelic; P A Sokol
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.